INDV (STOCKS)
Indivior Pharmaceuticals, Inc. Common Stock
$38.100000
-0.630000 (-1.63%)
Prev close: $38.730000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Joseph J. Ciaffoni
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $4,769.96M
- Employees
- 1,051
- P/E (TTM)
- 13.76
- P/B (TTM)
- -21.97
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
7
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$1.15 | $0.89 | +0.2583 | +28.97% |
|
Mar 2026 (Q1)
|
$0.96 | $0.67 | +0.2919 | +43.69% |
|
Dec 2025 (Q4)
|
$0.82 | $0.69 | +0.1325 | +19.27% |
|
Sep 2025 (Q3)
|
$0.72 | $0.42 | +0.3001 | +71.47% |
Financial Statements
| Revenues | $1.33B |
| Benefits Costs and Expenses | $938.00M |
| Cost Of Revenue | $240.00M |
| Costs And Expenses | $938.00M |
| Gross Profit | $1.09B |
| Operating Expenses | $671.00M |
| Selling, General, and Administrative Expenses | $589.00M |
| Other Operating Expenses | $82.00M |
| Operating Income/Loss | $421.00M |
| Income/Loss From Continuing Operations After Tax | $355.00M |
| Income/Loss From Continuing Operations Before Tax | $394.00M |
| Income Tax Expense/Benefit | $39.00M |
| Income Tax Expense/Benefit, Deferred | -$1.00M |
| Net Income/Loss | $355.00M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $355.00M |
| Net Income/Loss Available To Common Stockholders, Basic | $355.00M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $2.88 |
| Diluted Earnings Per Share | $2.79 |
| Basic Average Shares | 247,000,000 |
| Diluted Average Shares | 257,000,000 |
| Assets | $1.23B |
| Current Assets | $725.00M |
| Inventory | $150.00M |
| Prepaid Expenses | $14.00M |
| Other Current Assets | $561.00M |
| Noncurrent Assets | $508.00M |
| Fixed Assets | $162.00M |
| Other Non-current Assets | $346.00M |
| Liabilities | $1.44B |
| Current Liabilities | $868.00M |
| Accounts Payable | $30.00M |
| Wages | $71.00M |
| Other Current Liabilities | $767.00M |
| Noncurrent Liabilities | $573.00M |
| Equity | -$208.00M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | -$208.00M |
| Liabilities And Equity | $1.23B |
| Net Cash Flow From Operating Activities | -$40.00M |
| Net Cash Flow From Operating Activities, Continuing | -$40.00M |
| Net Cash Flow From Investing Activities | -$71.00M |
| Net Cash Flow From Investing Activities, Continuing | -$71.00M |
| Net Cash Flow From Financing Activities | -$174.00M |
| Net Cash Flow From Financing Activities, Continuing | -$174.00M |
| Net Cash Flow | -$285.00M |
| Net Cash Flow, Continuing | -$285.00M |
| Comprehensive Income/Loss | $360.00M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $360.00M |
| Other Comprehensive Income/Loss | $360.00M |
| Other Comprehensive Income/Loss Attributable To Parent | $4.00M |